Primary care physician perspectives on barriers to diagnosing axial Spondyloarthritis: a qualitative study by Lapane, Kate L. et al.
University of Massachusetts Medical School 
eScholarship@UMMS 
Open Access Articles Open Access Publications by UMMS Authors 
2020-09-29 
Primary care physician perspectives on barriers to diagnosing 
axial Spondyloarthritis: a qualitative study 
Kate L. Lapane 
University of Massachusetts Medical School 
Et al. 
Let us know how access to this document benefits you. 
Follow this and additional works at: https://escholarship.umassmed.edu/oapubs 
 Part of the Diagnosis Commons, Family Medicine Commons, Health Services Administration 
Commons, Health Services Research Commons, Musculoskeletal Diseases Commons, Primary Care 
Commons, and the Rheumatology Commons 
Repository Citation 
Lapane KL, Khan S, Shridharmurthy D, Beccia A, Dube CE, Yi E, Kay J, Liu S. (2020). Primary care physician 
perspectives on barriers to diagnosing axial Spondyloarthritis: a qualitative study. Open Access Articles. 
https://doi.org/10.1186/s12875-020-01274-y. Retrieved from https://escholarship.umassmed.edu/
oapubs/4345 
Creative Commons License 
This work is licensed under a Creative Commons Attribution 4.0 License. 
This material is brought to you by eScholarship@UMMS. It has been accepted for inclusion in Open Access Articles 
by an authorized administrator of eScholarship@UMMS. For more information, please contact 
Lisa.Palmer@umassmed.edu. 
RESEARCH ARTICLE Open Access
Primary care physician perspectives on
barriers to diagnosing axial
Spondyloarthritis: a qualitative study
Kate L. Lapane1,2* , Sara Khan1, Divya Shridharmurthy1,3, Ariel Beccia1,3, Catherine Dubé1, Esther Yi4,
Jonathan Kay1,5,6 and Shao-Hsien Liu1,5
Abstract
Background: The average delay in diagnosis for patients with axial spondyloarthritis (axSpA) is 7 to 10 years.
Factors that contribute to this delay are multifactorial and include the lack of diagnostic criteria (although
classification criteria exist) for axSpA and the difficulty in distinguishing inflammatory back pain, a key symptom of
axSpA, from other highly prevalent forms of low back pain. We sought to describe reasons for diagnostic delay for
axSpA provided by primary care physicians.
Methods: We conducted a qualitative research study which included 18 US primary care physicians, balanced by
gender. Physicians provided informed consent to participate in an in-depth interview (< 60 min), conducted in
person (n = 3) or over the phone (n = 15), in 2019. The analysis focuses on thoughts about factors contributing to
diagnostic delay in axSpA.
Results: Physicians noted that the disease characteristics contributing to diagnostic delay include: back pain is
common and axSpA is less prevalent, slow progression of axSpA, intermittent nature of axSpA pain, and in the
absence of abnormal radiographs of the spine or sacroiliac joints, there is no definitive test for axSpA. Patient
characteristics believed to contribute to diagnostic delay included having multiple conditions in need of attention,
infrequent interactions with the health care system, and “doctor shopping.” Doctors noted that patients wait until
the last moments of the clinical encounter to discuss back pain. Problematic physician characteristics included lack
of rapport with patients, lack of setting appropriate expectations, and attribution of back pain to other factors.
Structural/system issues included short appointments, lack of continuity of care, insufficient insurance coverage for
tests, lack of back pain clinics, and a shortage of rheumatologists.
Conclusion: Primary care physicians agreed that lengthy axSpA diagnosis delays are challenging to address owing
to the multifactorial causes (e.g., disease characteristics, patient characteristics, lack of definitive tests, system factors).
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Background
The average delay in diagnosis for patients with axial
spondylarthritis (axSpA) [1–3] ranges from 7 to 10 years
[4–8], with estimates as high as 13 years between symp-
tom onset and diagnosis in the United States [9]. The
significant diagnostic delay is a well-known feature of
spondyloarthritis management [10]. Patients with longer
delay in diagnosis (e.g., > 5 years) display more structural
damages and limited spinal mobility [11]. In addition,
patients may experience distress, depression, and desper-
ation associated with their prolonged search for diagno-
sis and treatment [12]. Therefore, the improvement of
delay in diagnosis for axSpA may slow disease progres-
sion and thus avoid or delay serious disability due to the
early treatment interventions and access to care [13].
The delay in diagnosis for axSpA is multifactorial in-
cluding characteristics of the patients, providers, health-
care system, and disease itself. For instance, patients
may seek care from different medical professionals with-
out guidance due to varied disease manifestations of
axSpA or the lack of proper access to care (e.g., limited
rheumatologists). Despite the use of sensitive imaging
tool such as magnetic resonance imaging, the delayed
diagnosis for patients with non-radiographic axSpA is
still significant [14]. On the other hand, physicians may
also play an important role in the early diagnosis of
axSpA. Despite the low awareness of axial SpA among
non-rheumatologist physicians [13], most axSpA pa-
tients are diagnosed by non-rheumatologists [15], with
rheumatologists having diagnosed only 37% between
2000 and 2012 [16]. Primary care physicians may have
difficulty discriminating inflammatory back pain from
other types of back pain and may be unaware of other
features that are important in making a diagnosis of
axSpA.
In this qualitative research study, we sought the per-
spectives of primary care physicians to gain a better un-
derstanding of the reasons for diagnostic delay in
primary care settings. We chose a qualitative approach
because qualitative data frequently yield surprising in-
sights and provide in-depth detail about participants’
perceptions and experiences that quantitative data often
cannot [17]. Such foundational knowledge may be useful
in developing interventions to reduce the delay in diag-
nosis of axSpA.
Methods
The University of Massachusetts Medical School Institu-
tional Review Board approved this study.
Study design
The physician in-depth interviews were part of a larger
qualitative study- The SpondyloArthritis Screening and
Early Detection (SpA-SED) Study. Our protocol was
guided by best practices for the conduct and reporting
of qualitative research (COREQ) [18]. The appropriately
completed COREQ checklist for the current study is in-
cluded (Appendix A).
Participant recruitment
We recruited 18 primary care physicians (a sample size
likely adequate to achieve saturation) who were willing
to participate in a recorded, 60-min in-depth discussion.
We used purposive sampling to enroll equal numbers of
men and women and family medicine and internal medi-
cine physicians. Thirty-four participants including those
who were known to the research team or their col-
leagues (approached by emails) or who were identified
through state and regional primary care professional so-
cieties (face-to-face) were invited to participate. Six de-
clined, nine were non-responders, and one physician was
not selected because of our need for balance by gender
and type of physician. All 18 participants participated in
scheduled interviews and completed the study. Partici-
pants were offered a cash card of $300 to compensate
for their time.
Study setting
The interviews were conducted either in person in a pri-
vate conference room in Rhode Island or Massachusetts
(n = 3) or over the phone (n = 15) between February–
May 2019. We conducted phone interviews using Zoom.
Interview guide
A multidisciplinary team developed the interview guide
(< 60min interviews, Appendix B). Questions included
experience with back pain, how back pain is evaluated,
what laboratory tests are ordered when axSpA is sus-
pected, what referrals participants would make, aware-
ness of axSpA, speculation about what contributes to
diagnostic delay in axSpA, etc. The average length of the
interviews was 47.1 min (standard deviation: 11.3).
Conduct of interviews
Interviews were conducted by experienced, trained
personnel (KLL, DS), with an observer from the research
team participating and taking notes. For one interview,
the research interviewer (KLL) had previously worked as
an investigator on a research project with the physician
participant (> 5 years previously). Research staff were
trained to assure standardized data collection. The
protocol was pilot tested with one physician. The re-
searchers conducting the interviews reported no obvious
bias but did report prior assumptions that lack of aware-
ness of axSpA and lack of time would emerge as leading
barriers to axSpA screening in primary care settings. No
repeat interviews were conducted.
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Data collection and management
The study data were collected and managed using RED-
Cap electronic data capture tools hosted at the Univer-
sity of Massachusetts Medical School [19]. REDCap
(Research Electronic Data Capture) is a secure, web-
based application designed to support data capture for
research studies, providing: 1) an intuitive interface for
validated data entry; 2) audit trails for tracking data ma-
nipulation and export procedures; 3) automated export
procedures for seamless data downloads to common
statistical packages; and 4) procedures for importing
data from external sources.
Analytic strategy
We conducted a group method of data analysis known
as immersion / crystallization [20]. Four team members
independently listened to selected interview recordings,
read in-depth transcripts, and wrote analytic notes for
each. The transcript texts were subjected to line-by-line
coding with NVivo qualitative software [21]. The code-
book was modified by team consensus. Searches for al-
ternative interpretations were conducted again and
discussed before final decisions were made about how to
report the findings of the study. This manuscript focused
on one parent node in our coding scheme: Reasons for
Diagnostic delay.
Feedback from participants
We prepared a preliminary report of our findings and
emailed participants who indicated they were willing to
review and provide feedback (Appendix C).
Results
Of the participants, 44% were women, 66.7% were non-
Hispanic white and 83.3% attended an allopathic medical
school in the United States (Table 1). All physicians con-
sidered that the length of diagnostic delay was problem-
atic, and all agreed that this delay was unacceptable.
Physicians believed that multiple factors were contribut-
ing to the diagnostic delay in axSpA. Figure 1 depicts
the multifactorial components perceived by primary care
providers participating in the study. Barriers to early
diagnosis included disease characteristics (e.g., slow dis-
ease progression; Table 2), patient factors (e.g., multiple
other conditions, back pain not chief complaint, Table 3),
physician characteristics (e.g., lack of rapport/trust,
Table 4), and structural/system issues (e.g., lack of time,
Table 5). Primary care physicians noted that, because
back pain is multifactorial and very common and axSpA
is not, axSpA may be missed. Physicians explained that
the slow progression of the disease may contribute to
the diagnostic delay. The intermittent nature of symp-
toms and range of symptoms severity related to axSpA
also was noted as a factor contributing to diagnostic
delay. Additionally, physicians pointed out that it takes
time for radiographic evidence to appear and that there
are no other definitive diagnostic tests.
A common theme was that patients do not interact
frequently enough with the health care system and the
lack of continuity of care (Table 3). Primary care physi-
cians uniformly noted that patients often have multiple
issues to discuss and back pain is mentioned only at the
very end of the visit. Physicians did not discuss why pa-
tients waited until the last moment to share their com-
plaints of back pain. Some physicians explained that
they are likely to attribute back pain to other conditions
(Table 4); most emphasized the need to establish trust
and a good rapport with patients. The importance of set-
ting appropriate expectations with patients was noted,
since back pain may not be addressed adequately in one
Table 1 Characteristics of physicians
Total
(n = 18)
Age (years), mean (SD) 46.8 (12.6)
Women, % 44.4
Race/ethnicity, %
Non-Hispanic, White 66.7
Non-Hispanic, Black 5.6
Hispanic 5.6
Other 22.2
Trained at, %
US Allopathic school 83.3
US Osteopathic school 0
Foreign medical school 16.7
Years in practice, mean (SD) 15.9 (13.0)
Practice characteristics: % (check all that apply)
Individual 0
≤ 5 physicians 27.8
≥ 6 physicians 55.6
Hospital-based practice 38.9
Academic affiliation 66.7
Confidence in distinguishing inflammatory versus mechanical back pain,
%
Not confident 16.7
Somewhat confident 38.9
Very confident 33.3
Extremely confident 11.1
Knowledge of inflammatory back pain classification criteria, %
Calin criteria 0
ASAS criteria 16.7
Berlin criteria 0
ASAS Assessment of Spondyloarthritis International Society
SD Standard Deviation; Percentages may exceed 100% due to rounding
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Fig. 1 Factors influencing timely diagnosis of axSpA
Table 2 Disease characteristics contributing to diagnostic delay for patients with axSpA
Sample Quotes
Back pain is very common, axSpA
is not
D25: in primary care general practice, … there’s the old adage when you hear hoofbeats, think horses, not
zebras. So, ankylosing spondylitis is a zebra.
D10: it’s certainly not on the top three things I think of when somebody comes in and says my back hurts. So,
and, you know, I’m not sure if I’m just missing it because I’m not looking for it or is it just relatively rare
Slow disease progression D34: Or things behave similarly early on, and advanced imaging or blood tests may be easy not to do based on
let’s try this, let’s try that, and if things don’t get better, that usually is that patients come back and other
symptoms start arising. So it might take a while for more systemics to arise that might put that on the radar of
the physician to work up further.
D5: You know, it progresses over time and you -- before you get to bamboo spine.
Intermittent nature of pain with
axSpA
D24: Well, patients are often, when they’re uncomfortable -- well, unless they’re getting, you know, they’re
having a flare and then nothing for a few years and then getting a flare, nothing.
D22: a lot of pain generally improves with time, especially acute -- either acute pain or acute flareup sorts of
pain, so it kind of gives the patient, you know, a couple of weeks. Usually by that time the pain always -- almost
always goes away.
Lack of characteristic radiographic
appearances
D11: Part of the delay, one would think, is probably related to the lack of characteristic radiographic appearance
of -- sacroiliitis sounds great for you and I to talk about but the radiograph isn’t always, you know, knock your
socks off. It takes a while until you start obscuring the joint margin.
D22: The patient was there for something else and he said that okay, I’ve been having a lot of stiffness in the
morning and that was – he had typical symptoms but when we did his x-ray there was nothing specific.
No definitive test for diagnosis D24: I would probably move to imaging before I would get something like a B27 simply because -- and, I’ll be
honest, I don’t know the percentages here, … we have more back pain from arthritis and disks and it’s such a
common problem. The amount of people who are going to have a positive B27 is fairly low.
D3: I have sent them for a work up. Most of the time it’s been negative.
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visit. Primary care physicians lamented that the limited
amount of time available for appointments impedes their
ability to diagnose axSpA in a timely fashion (Table 5).
Further, physicians noted that the lack of continuity of
care may contribute to diagnostic delay. Patient con-
cerns about the expense of copayments expected when
undergoing testing needed to evaluate axSpA may also
contribute to the diagnostic delay. The lack of dedicated
spine clinics and the shortage of rheumatologists were
reported as barriers to timely diagnosis.
Discussion
This study sheds light on the challenges faced by pri-
mary care physicians that may contribute to the delay in
diagnosing axSpA, which typically presents with the
insidious onset of back pain that often is attributed to
other, more prevalent conditions [22, 23]. The subjective
quality of pain may be difficult for patients to describe
and is not easily measured objectively. In our study, pri-
mary care physicians noted that axSpA patients may not
interact frequently enough with the health care system
to facilitate a correct diagnosis. Consistent with previous
research [16], lack of diagnostic criteria, lack of definitive
biomarkers, and lack of radiographic confirmation of
axSpA until later in the disease course [13, 24] were
identified as factors contributing to axSpA diagnostic
delay.
Several physician-related factors that may contribute
to diagnostic delay were identified, including a lack of
awareness about axSpA among non-rheumatology health
Table 3 Patient characteristics contributing to diagnostic delay for patients with axSpA
Sample Quotes
Patients may not interact frequently enough
with the health care system
D1: And it’s also possible that it might occur in people with less access to healthcare because of
socioeconomic reasons.
D23: It could be that patients aren’t going in until a lot later because they don’t want to see a
doctor, they’re nervous about the diagnosis …
Patients having multiple issues to discuss D7: They bring in a list and then they say okay, I have a list and if I have a list you have to pay
attention to it all and then I’m like when we’re at number ten or number 13, we’re not going
there. But we realize it’s a negotiation and the biggest challenge is when you just don’t have time.
D27: I mean, if patients haven’t accessed the medical system often enough or at all, they will come
in with a -- like a laundry list of six or seven or eight problems, and I -- my approach is often, like,
let’s talk about your top two.
Patients often add back pain onto the list at the
last moment
D12: They’re clearly the visit’s scheduled for the back pain, and that’s the main theme of the
discussion for that visit. … [it] also sometimes comes up when they’re here for something else and
they would say, “Oh, by the way, my back has been hurting,” or, “I have a bad back”.
Patients doctor shop and concern about
malingering
D22: A lot of patients do go from one doctor to the other and that always doesn’t help because
the next doctor, they’ve seen the patient for 1 month only and then they start the whole process
again, and the patient goes through a battery of tests.
D23: well, but they also hop physicians because they feel like what they’re doing isn’t helping me,
but I think that’s the problem is they’re assuming that there aren’t other things that can be
addressed or looked at.
Table 4 Physician characteristics that may reduce diagnostic delay for patients with axSpA
Sample Quotes
Establish trust and good rapport with
patients
D23: I think also if a patient actually establishes rapport with the doctor and there’s a good doctor-patient re-
lationship and they are familiar with each other, if something like this does crop up, it is out of the ordinary
based on what the doctor knows of the patient.
D23: I think what it really comes down to just trust and open relationship with the doctor and the patient.
D31: Some of my colleagues don’t listen well enough to patients and they miss things. Actively listening to
the patient is going to be the most important thing I think any physician -- most important skill that I think
any physician can possess, actively listening. Talking less and listening more. Because I always learned when I
was a medical student that, you know, your patient is going to give you the diagnosis, all you have to do is
listen.
Setting appropriate expectations D3: But if its somebody who is coming in who has had chronic back pain, has had a lot of work up, has had
good intervention, then I think that’s somebody where I’m starting to turn on my radar and thinking, “Okay,
is there something else that I’m missing here that’s not just your run in the mill.
D27: I would be seeing them in follow up and noticing that they didn’t resolve typically, and I would
probably be -- in my next exam be doing a review of systems again to find those other systems that were
involved.
Some physicians attribute back pain
to other factors
D10: It’s certainly not on the top three things I think of when somebody comes in and says my back hurts.
… I’m not sure if I’m just missing it because I’m not looking for it or is it just relatively rare.
D24: they’re saying well, yeah, but I was in a car accident when I was 18 and I rolled the car and, you know,
so my back has been hurting me off and on since I was then -- you know, now that I’m, you know, 35 and
I’ve put on some weight and I don’t exercise anymore, my back is hurting.
Lapane et al. BMC Family Practice          (2020) 21:204 Page 5 of 11
care professionals [9]. Lack of trust, poor rapport, inef-
fective communication, and misaligned expectations be-
tween providers and patients were factors that likely
contribute to diagnostic delay. Among patients with
immune-mediated inflammatory diseases, distrust of
health care providers has been associated with poor
medication adherence [25] while, conversely, good
patient-provider communication has been shown to im-
prove health outcomes [26]. Our participants also re-
ported that patients may not realize that axSpA often is
not diagnosed during a single visit, but rather involves a
journey that occurs over a period of time. Physicians
mentioned that infrequent contact with the health care
system and lack of continuity of care contributed to the
diagnostic delay. To our knowledge, research has not
been conducted on whether discordant expectations be-
tween patients being evaluated for axSpA and their pri-
mary care physicians contributes to diagnostic delay.
Nevertheless, improved alignment of patient expecta-
tions to care processes may improve patient continuity
of care.
Primary care physicians mentioned system-level fac-
tors that impede timely diagnosis of axSpA, including
the short appointment length and difficulty arranging
rheumatology referrals. The median length of a primary
care visit was 15.7 min, during which a median of six
topics were covered with ~ 5min spent discussing the
primary complaint and 1.1 min on each remaining topic
[27]. A musculoskeletal or rheumatologic condition
accounted for the chief complaint in only about 8.3% of
primary care visits [28], which is consistent with reports
by providers in our study that mention of back pain may
be withheld by patients until the end of the clinical en-
counter. Patients with axSpA often have multiple condi-
tions, such as hypertension and depression, which might
supersede back pain as the main focus of a primary care
visit [29]. Given the challenges of reduce time with pa-
tients and increased complexity of patient issues, auto-
mated tools may be useful to primary care physicians to
identify uncommon diseases such as axSpA.
Delays in diagnosis of axSpA also have been attributed
to late referral of patients with inflammatory back pain
by general practitioners to rheumatologists [15, 16, 30,
31]. However, the average wait for a rheumatology ap-
pointment is 4 months [32]. Difficulty accessing rheuma-
tology care is exacerbated by the shortage of and decline
in the number of practicing rheumatologists [33]. By
2025, the demand for rheumatologists is projected to ex-
ceed supply and a shortage of 3845 rheumatologists is
predicted [34, 35]. This shortage results in burdens for
patients, including excessive travel time – which may ex-
ceed 90 min for some patients [36]. The American Col-
lege of Rheumatology has proposed multiple strategies
to address this workforce shortage, but the extent to
which these will be successful remains uncertain.
Limitations must be considered. Most of the partici-
pants practiced in Massachusetts and Rhode Island and
had academic affiliations. Systems factors may be spe-
cific to local context. Physicians with academic affilia-
tions may be more aware of axSpA. Patient factors were
Table 5 System/structural characteristics contributing to diagnostic delay for patients with axSpA
Sample Quotes
Length of time for appointments
needs to be longer
D27: Time is a constraint. I would love to have 30 min for every problem a patient comes in and then I think
this wouldn’t be an issue.
Lack of continuity of care D3: Well, I would actually wonder how many of those people were not getting regular care like with the
same physician, like continuous care. So, you know a lot of say younger people who go to an urgent care
center are like you know … “Oh, I’m here and I’ve got low back pain” and for the doctor it’s like, let me give
them a shot of Toradol and send them on their way, “Here’s some anti-inflammatory meds, follow up with
your primary care.”
D32: They [patients] get kind of used to the pain, and they’ve kind of seen doctors who have examined
them and said, hey, everything looks fine. You don’t need to keep coming in.
Costs of tests expensive D24: I see so many people with back pain, a subset of those I test for autoimmune diseases, but even when
I’m doing that, if I’m going to test or something like B27, I can’t really use it as a screening test because
insurance doesn’t pay for those sort of tests just for a diagnosis of back pain … Uveitis, I think it will get
covered, but, I mean, people get upset when they get a big bill; why did you do all these blood tests on
me?
D12: Once I see, yes, it’s heading in that direction, I’ll probably do blood work and their clear blood work,
ANA, HLA-B27, which I kind of wait, because it might be an expensive.
Lack of back pain clinics D11: Chronic back pain, no one wants to see them, no one wants to own them.
D29: Yeah, so our orthopedists don’t see back, so only our neurologist will see our back patients, if we have
anybody. I don’t think rheum sees back.
D28: Oh, yeah; it’s the most difficult thing to -- the single worst referral is the referral for the rheumatologist.
Shortage of available rheumatologists D31: The issue is we don’t have many rheumatologists at all. There’s a shortage. … the nearest
rheumatologist, I think, is probably going to be at least an hour drive away or maybe like 45–50miles.
D24: We don’t have rheumatology in our county, so that’s an out of county referral and much harder to get
an appointment.
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Appendix A
Table 6 COREQ (COnsolidated criteria for REporting Qualitative research) Checklist
Domain and Items Page Number Reported
Domain 1: Research team and reflexivity
Personal characteristics
1. Interviewer/facilitator
Which author/s conducted the interview or focus group?
Page 5.
The first and third-named authors listed conducted the interviews.
2. Credentials
What were the researcher’s credentials?
Page 1.
3. Occupation
What was their occupation at the time of the study?
Page 1.
4. Gender
Was the researcher male or female?
N/A.
5. Experience and training
What experience or training did the researcher have?
Page 5.
Relationship with participants
6. Relationship established
Was a relationship established prior to study commencement?
This is acknowledged on Page 5: “Thirty-four participants including those
who were known to the research team or their colleagues (approached
by emails) or who were identified through state and regional primary care
professional societies (face-to-face) were invited to participate.”
7. Participant knowledge of the interviewer
What did the participants know about the researcher? e.g. personal
goals, reasons for doing the research
Following on from above, some participants known to the research team
were recruited. While a few of the participants knew the researcher (KLL),
none knew of any personal goals or reasons for doing the research.
Participants received a fact sheet about the research (including its aims
and rationale) and had the opportunity to ask the researcher additional
questions prior to deciding if they wished to participate.
Page 11: “All participants provided informed consent.”
8. Interviewer characteristics
What characteristics were reported about the interviewer/facilitator? e.g.
Bias, assumptions, reasons and interests in the research topic
Page 5–6.
Domain 2: study design
Theoretical framework
9. Methodological orientation and Theory What methodological
orientation was stated to underpin the study? e.g. grounded theory,
discourse analysis, ethnography, phenomenology, content analysis
Page 6.
Participant selection
10. Sampling
How were participants selected? e.g. purposive, convenience,
consecutive, snowball
Page 5.
11. Method of approach
How were participants approached? e.g. face-to- face, telephone, mail,
email
Page 5.
12. Sample size
How many participants were in the study?
Page 5.
13. Non-participation
How many people refused to participate or dropped out? Reasons?
Page 5.
Setting
14. Setting of data collection Where was the data collected? e.g.
home, clinic, workplace
Page 5.
15. Presence of non-participants Was anyone else present besides the
participants and researchers?
Page 5.
“Interviews were conducted by experienced, trained personnel (KLL, DS),
with an observer from the research team participating and taking notes.”
16. Description of sample
What are the important characteristics of the sample? e.g. demographic
data, date
Page 5 & 7.
Data collection
Lapane et al. BMC Family Practice          (2020) 21:204 Page 7 of 11
Table 6 COREQ (COnsolidated criteria for REporting Qualitative research) Checklist (Continued)
Domain and Items Page Number Reported
17. Interview guide
Were questions, prompts, guides provided by the authors? Was it pilot
tested?
Page 5–6.
18. Repeat interviews
Were repeat interviews carried out? If yes, how many?
Page 6. “No repeat interviews were conducted.”
19. Audio/visual recording
Did the research use audio or visual recording to collect the data?
Page 5. “We conducted phone interviews using Zoom.”
20. Field notes
Were field notes made during and/or after the interview or focus group?
Page 5.
21. Duration
What was the duration of the interviews or focus group?
Page 5.
22. Data saturation
Was data saturation discussed?
Page 5.
23. Transcripts returned
Were transcripts returned to participants for comment and/or
correction?
N/A.
Domain 3: analysis and findings
Data analysis
24. Number of data coders
How many data coders coded the data?
Page 6.
25. Description of the coding tree
Did authors provide a description of the coding tree?
Page 6.
26. Derivation of themes
Were themes identified in advance or derived from the data?
Page 6.
27. Software
What software, if applicable, was used to manage the data?
Page 6.
28. Participant checking
Did participants provide feedback on the findings?
Page 6.
Reporting
29. Quotations presented
Were participant quotations presented to illustrate the themes /
findings? Was each quotation identified? e.g.
participant number
Page 15–19: Table 2, 3, 4 and 5
30. Data and findings consistent
Was there consistency between the data presented and the findings?
Page 7; Page 15–19: Tables 2, 3, 4 and 5
31. Clarity of major themes
Were major themes clearly presented in the findings?
Page 15–19: Tables 2, 3, 4 and 5
32. Clarity of minor themes
Is there a description of diverse cases or discussion of minor themes?
N/A.
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Appendix B
Table 7 Codebook for primary care physician interviews
Name Description
Patient characteristics Any mention of these sociodemographic factors, as they relate to diagnosing, “textbook cases”, thoughts about axSpA,
etc.
a. Age
b. Weight-status/obesity
c. Sex/gender
d. Socioeconomic status
e. Employment
f. Multiple comorbidities
Approaches to diagnosing
axSpA
All quotes falling under this code should refer to axSpA specifically, not general back pain, acute injuries, etc.
a. Typical presentation of axSpA
b. Clues within workup pointing towards axSpA
c. Triggering events
d. Medical history
e. Imaging and lab tests if axSpA is suspected
f. Ruling out other diagnoses
Reasons for diagnostic
delay
a. Back pain is common and causes are multifactorial
b. axSpA is rare and has vague/nebulous symptoms
c. Challenges faced by PCPs regarding rare/specialized conditions
d. Structural barriers within healthcare system
e. Wary of drug seeking behavior
Overcoming delays Factors that could reduce the diagnostic delay (note: can include the need to implement a screening process)
Referrals a. Access
b. Physical therapy
c. Rheumatology
d. Other specialists
Screening a. Barriers = what makes screening difficult
b. Facilitators = what would make screening easier or likely to be implemented
c. General thoughts = current approaches, brainstorming other strategies currently being used or that could be used
(e.g., NLP)
axSpA Awareness Brief response to question about whether they and/or colleagues are aware of axSpA and whether they believe the
diagnostic delay is an issue
Screening questions a. Question 1: Have you suffered from back pain for more than 3months?
b. Question 2: Did your back pain start when you were aged 40 or under?
c. Question 3: Did your back pain develop gradually?
d. Question 4: Does your back pain improve with exercise?
e. Question 5: Do you find there is no improvement in your back pain when you rest?
f. Question 6: Do you suffer from back pain at night which improves upon getting up?
g. Recommendations
Appendix C
Table 8 Feedback from physician participants on preliminary report
Participant Comments
D31 Thank you for sharing the preliminary results of the study on inflammatory spondyloarthropathies and screening mechanisms for
primary care. I was pleased to have participated. I do have additional recommendations from a physician perspective but am delight to
learn that the next stage of your analysis will move to getting the input of patients through real-time interviews. Congratulations on ex-
cellent work and bringing importance to an often overlooked arthropathy in our clinics due to misdiagnosis. We must be willing, as
physicians, to take detailed medical histories and do physical examinations to get to root, and please do spread knowledge of the
screening tool and considering incorporating into medical apps such as Medscape and QxMD. That will help.
D34 Overall the summary for each section the comments make sense with regard to:
- the limitation of history taking questions to help dx axSpA
- the difficulties in making the diagnosis of axSpA
- the limitations of screening questions\screening tools
axSpA is a difficult dx to make given how common back pain is seen in the primary care’s office. Even using screening tools either filled
out by the patient or used by the provider still those would still have significant limitations making them not clinical useful in a busy
out-pt. setting.
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reported by the physician participants and are de-
rived from experiences with their own patients. It is
possible that physicians only had experience with pa-
tients with ankylosing spondylitis. Misinterpretations
of direct quotes may have occurred, although the
analytic approach used reduced this likelihood. How-
ever, despite these potential limitations, our findings
appear to be aligned with previous research [16].
Conclusions
Aiming to provide a better understanding of the rea-
sons for diagnostic delay in primary care settings, this
study identified primary care physicians’ perceptions
of several root causes of diagnostic delay in axSpA.
These contributing factors of delay in diagnosis for
axSpA were believed to be multifactorial and were at-
tributed to characteristics of patients, providers, the
healthcare system, and the disease itself. While in our
study primary care physicians felt that the diagnostic
delay reported in the literature is lengthy, it must be
noted that Primary care physicians believed that strat-
egies to address these barriers and reduce delay in
diagnosis of axSpA are needed. Early diagnosis of
axSpA is difficult and as such solutions to shorten
the diagnostic journey must consider the multitude of
contributing factors (i.e., patient, disease, physician,
system).
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